Risk Assessment in Patient Selection for Transcatheter Aortic Valve Replacement

Joseph A Walsh 3rd; Paul S Teirstein; Curtiss Stinis; Matthew J Price

doi:10.1016/j.iccl.2014.09.001

Risk Assessment in Patient Selection for Transcatheter Aortic Valve Replacement

Interv Cardiol Clin. 2015 Jan;4(1):1-12. doi: 10.1016/j.iccl.2014.09.001. Epub 2015 Feb 9.

Authors

Joseph A Walsh 3rd¹, Paul S Teirstein¹, Curtiss Stinis¹, Matthew J Price²

Affiliations

¹ Division of Cardiovascular Diseases, Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA.
² Division of Cardiovascular Diseases, Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: price.matthew@scrippshealth.org.

PMID: 28582117
DOI: 10.1016/j.iccl.2014.09.001

Abstract

Risk assessment models for transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement in high-risk patients and TAVR versus palliation in inoperable patients are based on surgical data and have limited discrimination and calibration in the setting of TAVR. Several novel risk models specifically designed for TAVR have improved discrimination over existing models but require further validation. Several clinical and echocardiographic variables, such as chronic lung disease, mitral regurgitation, and stroke volume index, influence outcomes. This article reviews current and novel risk models and important predictors of TAVR outcomes and proposes a framework to integrate them into clinical decision-making for patients with severe, symptomatic aortic stenosis.

Keywords: Aortic stenosis; Echocardiography; Risk assessment; Transcatheter aortic valve replacement; Valvular heart disease.

Publication types

Review